Q1
ANGO — Q1 FY2027 Financial Report Analysis
AngioDynamics grew fiscal Q1 2027 sales 6.9% to $80.9M on 13.2% Med Tech growth; gross margin rose to 59.4% (57.8% before tariff refunds) and the net loss narrowed to $7.1M, but full-year guidance was only reiterated.